Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ciclosporin to Protect Renal Function In Cardiac Surgery: CiPRICS A Phase II Double Blind Randomized Placebo Controlled Study

Next Previous
X
Search
Trial Profile

Ciclosporin to Protect Renal Function In Cardiac Surgery: CiPRICS A Phase II Double Blind Randomized Placebo Controlled Study

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Acute kidney injury
  • Focus Proof of concept; Therapeutic Use
  • Acronyms CiPRICS

    • Most Recent Events

    • 13 Oct 2016 According to NeuroVive Pharmaceutical media release, the company has announced results from the exploratory phase II CiPRICS trial.
    • 07 Sep 2016 According to NeuroVive media release, data from this trial will be presented at the Rodman & Renshaw 18th Annual Global Investment Conference.
    • 30 Aug 2016 According to NeuroVive media release, an oral presentation of this trial will be presented at the Swedish Thorax meeting in October, 2016. Data collection and an initial results analysis is estimated to be completed at this time point.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top